MetabolicEmerging Evidence

AOD-9604

Also known as: Fragment 177-191, hGH fragment

Growth hormone fragment that promotes fat loss through lipolysis without affecting IGF-1 or glucose.

Evidence

Emerging

FDA status

Not FDA-approved

Source

Synthetic hGH fragment (amino acids 177-191)

Overview

Growth hormone fragment that promotes fat loss through lipolysis without affecting IGF-1 or glucose.

Mechanism of Action

Binds beta-3 adrenergic receptors on adipocytes, increases cAMP/PKA signaling, activates hormone-sensitive lipase for lipolysis, inhibits lipogenic enzymes, no GH receptor binding (no IGF-1 elevation), preferentially accumulates in adipose tissue.

What research has looked at

Effects reported in studies, not proven benefits. See the evidence section below for how strong the research is.

  • Promotes fat breakdown (lipolysis)
  • Inhibits new fat formation (lipogenesis)
  • Body fat in animal studies
  • No effect on blood glucose or insulin
  • Fat tissue in animal studies
  • May support cartilage repair

Researched for

Research topics, not approved uses.

ObesityMetabolic syndromeVisceral adiposityBody compositionPotential for osteoarthritis (cartilage repair)

How Gabriel approaches peptides

Through Gabriel, licensed clinicians may prescribe BPC-157, TB-500, MOTS-c, epitalon and semax (nasal) as compounded medications from licensed 503A pharmacies, under HHS's October 28, 2026 interim policy, and only when appropriate. They are not FDA-approved, and Gabriel never gives peptide dosing. AOD-9604 isn't prescribed through Gabriel. If you're thinking about it, Gabriel can help you find a licensed clinician to look at the cause of what you're dealing with and the options with stronger evidence.

Read the peptide therapy guide

Research & Evidence

Evidence Level
Emerging
Studies

Animal studies, human trials for obesity

Summary

Animal studies reported fat loss. Human trials did not show meaningful weight loss, and development for obesity stopped.

Safety Information

Potential Side Effects

  • •Injection site reactions
  • •Headache (rare)

Contraindications

  • Pregnancy
  • Breastfeeding

Interactions

  • ⚠None well-documented

Quick Facts

CategoryMetabolic
SourceSynthetic hGH fragment (amino acids 177-191)
StatusNot FDA-approved